SpyBiotech
SpyBiotech is utilising unique protein superglue technology to develop vaccines against infectious disease and cancer.
- What
- Life Sciences
- When
- Mar 2017
- CEO
- Mark Leuchtenberger
- Status
- Private
- Investment
- Active
- OSE Board Director
- Katya Smirnyagina